Our Solutions

• finished dosage forms development
• optimization of existing formulations
• life Cycle Management
• generic & Generic Plus development

All conventional dosage forms can be developed at Bertin Pharma, manufactured & packed for use in clinical trials.

Dry Formulations (oral route)

• blending
• compression
• tablets (mono/multi-layers, plain or coated)
• capsules
• multi-particle systems (powder, pellets, granules, micro-tablets)
• implants
• soft & liquid filled capsules

Liquid & Semi-Solid Formulations (oral and topical route)

• aqueous and non aqueous solutions
• aqueous and non aqueous suspensions
• gels, emulsions, micro-emulsions
• ointments
• syrups
• micro/nano-emulsions
• semi-solids such as creams, gels, ointments

Formulations for the Parenteral Route

• aqueous and non aqueous solutions/emulsions
• dry solids
• suspensions
• polymeric Sustained Release Systems
• sachets of powder, semi-solids or liquids
• injectable

Modified Release Tablets

• delayed
• sustained
• bimodal
• gastro-resistant

Selection of Appropriate Sterilization Methods

• terminal sterilization
• sterilization of drug & solvent separately & combination of two aseptically
• sterile filtering & aseptic Filling

Our experts are trained on a wide range of dosage forms with small to medium-size manufacturing equipment from 2 kg/5 liters up to 120 kg/50 liters.

Development and manufacturing reports are generated to fill-in the IMPD or the CTD.

For the specific needs of double-blind clinical trials, Bertin Pharma can develop a placebo matching the study drug product or an over-encapsulated solid dosage form.